1Nikitidou O, Liakopoulos V, Kiparissi T, et al. Peritoneal dialysis-related infections recommendations: 2010 update. What is new?[J]. Int Urol Nephrol, 2012, 44(2): 593-600.
3Fontan MP, Treatment Cambre HD, Rodrfguez- Carmona A, et al. of peritoneal dialysis - related peritonitis with ciprofloxacin monotherapy: clinical outcomes and bacterial susceptibility over two decades[J]. Perit Dial Int, 2009, 29(3): 310-318.
4Govindarajulu S, Hawley CM, McDonald SP, et al. Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases[J]. Petit Dial Int, 2010, 30(3): 311-319.
5Chao CT, Lee SY, Yang WS, et al. Citrobacter peritoneal dialysis peritonitis: rare occurrence with poor outcomes[J]. Int J Med Sci, 2013, 10(9): 1092-1098.
6Shemin D, Maaz D, St Pierre D, et al. Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients[J]. Am J Kidney Dis, 1999, 34(1): 14-20.
7Badve SV, Hawley CM, McDonald SP, et al. Use of aminoglycosides for peritoneal dialysis- associated peritonitis does not affect residual renal function[J]. Nephrol Dial Transplant, 2012, 27(1): 381-387.
8Baker R J, Senior H, Clemenger M, et al. Empirical aminoglycosides for peritonitis do not affect residual renal function[J]. Am J Kidney Dis, 2003, 41(3): 670-675.
9Kumar KV, Mallikarjuna HM, Gokulnath, et al. Fungal peritonitis in continuous ambulatory peritoneal dialysis: The impact of antifungal prophylaxis on patient and technique outcomes[J]. Indian J Nephrol, 2014, 24(5): 297-301.
